Company Description
QIAGEN let the "gene-ie" out of the bottle. The company makes the tools researchers need to extract and purify nucleic acids (DNA/RNA), making them...
Key QIAGEN Financials
| Company Type | Public - NASDAQ (GS): QGEN; German: QIA Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2006 Sales (mil.) | $465.8 |
| 2006 Employees | 1,954 |
More QIAGEN Financials (11 pages)
Rankings
- TecDAX
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the discovery...
Read more about QIAGEN's competition across multiple industries
Top QIAGEN Competitors
Sponsored Links
The Business DirectoryQIAGEN Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman, Supervisory Board | Prof Detlev H. Riesner | Network | E-mail |
| Managing Director and CEO | Peer M. Schatz | Network | E-mail |
| Managing Director and CFO | Roland Sackers | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current QIAGEN News
- FedBizOpps/CBD [FedBizOpps] (19 Aug 2008 00:01:00 EDT)
- FedBizOpps/CBD [FedBizOpps] (14 Aug 2008 00:01:00 EDT)
- FedBizOpps/CBD [FedBizOpps] (08 Aug 2008 00:01:00 EDT)
Sponsored Opportunity










